The fourth edition of Pharmacotherapy Principles & Practice is designed to provide student
learners and health care practitioners with essential knowledge of the pathophysiology and …

… Although locally advanced squamous cell carcinoma of the head and neck (SCCHN) is
potentially curable with combined-modality therapy, recurrent or metastatic (R/M) disease …

Introduction Vorinostat is a small molecule inhibitor of histone deacetylase, and has shown
preclinical activity in non-small cell lung cancer (NSCLC). Methods Patients with relapsed …

Poly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles have a proven
capacity for drug solubilization and have entered phase III clinical trials as a substitute for …

To the Editor: Results from large-scale phenome-wide association studies (PheWAS) allow
association of genetic variants with a wide spectrum of human disorders and have provided …

Background: Lapatinib is an oral, small-molecule, reversible inhibitor of both epidermal
growth factor receptor (EGFR) and human epidermal growth factor receptor-2 (HER2) tyrosine …

PURPOSE We conducted this systematic review to evaluate the clinical outcomes associated
with molecular tumor board (MTB) review in patients with cancer. METHODS A systematic …

Purpose The prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN)
are reviewed. Summary A number of agents, including amifostine, glutathione, and …

Ovarian cancer is the most-deadly gynecologic malignancy, with greater than 14,000
women expected to succumb to the disease this year in the United States alone. In the front-line …

Background: The objective of ECOG 1503 was to determine the response rate of this combination
in the second-line treatment of advanced NSCLC. Methods: Triapine 105 mg/m 2 IV on …